The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews (PEPPR)

This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.

Study Overview

• Status: Unknown
• Conditions: Accidental Fall; Pharmaceutical Preparations; Allied Health Personnel
• Intervention / Treatment: Other: Survey

Detailed Description

Falls in people aged 65 years and over are a common reason for calling the emergency ambulance service. Falls can be serious, with about 1 in 20 people having to be taken to hospital because they have been injured. Thankfully, in more than 4 out of 10 cases, people are not seriously injured and can be left at home. However, it is important that the reason for the fall is found and future falls are prevented where possible.

Yorkshire Ambulance Service can already make a referral to another local service to get specialist practical help for falls prevention when people are left at home after a fall. Research has shown that the safe use of medicines can prevent future falls, but that did not form. Now a new service has been set up for Yorkshire Ambulance Service to refer patients to the Leeds GP Confederation. A pharmacist working in the patients GP surgery will undertake a review of the patient's use of their medicines.

We would like to find out about how patients feel about using their medicines before and after the medicines review by a pharmacist. We would also like to know how they feel about the medicines review itself, to help decide whether this scheme should continue or be expanded to other areas. To do this, we are going to send a questionnaire to patients who receive a medicines review. The questionnaire will be sent by post, take about 10 minutes to fill out and include a stamped addressed envelope so people who take part will not have to pay for postage.

• Study Type: Observational
• Enrollment (Anticipated): 132

Contacts and Locations

Study Locations

• United Kingdom
  • West Yorkshire
    • Wakefield, West Yorkshire, United Kingdom, WF2 0XQ
      • Recruiting
      • Yorkshire Ambulance Service NHS Trust
      • Principal Investigator: Rebecca McLaren
      • Contact: Jane Shewan; Phone Number: +441924584224; Email: yas.ressearch@nhs.net

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 110 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

This study will be conducted from a single site (Yorkshire Ambulance Service NHS Trust). YAS staff make around 70-100 falls referral pathways a month in the Leeds area, and after exclusions relating to the PREFACS projects, it is anticipated that around 55 patients per month will be eligible to receive a pharmacist-led clinical medication review and will therefore be eligible for this study, up to a maximum of 550 patients.

Description

Inclusion Criteria:

• Received a pharmacist-led clinical medication review following a falls referral made by a paramedic from Yorkshire Ambulance
• Registered with a GP in the Leeds area
• Has capacity to consent to take part in the study

Exclusion Criteria:

• Did not receive a pharmacist-led clinical medication review after a Yorkshire Ambulance Service paramedic made a falls referral
• Not registered with a GP in the Leeds area
• Does not have capacity to consent to take part in the study

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Proportion of patients who express a change in emotion relating to how they feel about their medicines, following a pharmacist-led clinical medication review.	1 month

Secondary Outcome Measures

Outcome Measure	Time Frame
Patient expressed emotion	1 month

Collaborators and Investigators

• Sponsor: Yorkshire Ambulance Service NHS Trust
• Collaborators: NIHR Yorkshire and Humber Patient Safety Translational Research Centre

Study record dates

Study Major Dates

• Study Start (Actual): July 24, 2019
• Primary Completion (Anticipated): June 30, 2020
• Study Completion (Anticipated): June 30, 2020

Study Registration Dates

• First Submitted: May 2, 2019
• First Submitted That Met QC Criteria: May 2, 2019
• First Posted (Actual): May 6, 2019

Study Record Updates

• Last Update Posted (Actual): August 12, 2019
• Last Update Submitted That Met QC Criteria: August 7, 2019
• Last Verified: August 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: YASRD114; 263976 (Other Identifier: IRAS)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No